Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Accepted for publication January 9, 2019
- Published online November 1, 2019.
Article Versions
- Latest version (January 15, 2019 - 04:00).
- Latest version (January 15, 2019 - 11:15).
- Latest version (June 1, 2019 - 04:00).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2019 Free online via JRheum Full Release option
Author Information
- Victor S. Sloan⇑,
- Anna Sheahan,
- Jeffrey L. Stark and
- Robert Y. Suruki
- From UCB Pharma, Raleigh, North Carolina; Rutgers-Robert Wood Johnson Medical School, New Brunswick, New Jersey; UCB Pharma, Smyrna, Georgia, USA.
- V.S. Sloan, MD, FACP, FACR, Vice President and Development Strategy Lead (Immunology), UCB Pharma, Raleigh, and Clinical Associate Professor of Medicine, Rutgers-Robert Wood Johnson Medical School; A. Sheahan, PhD, Real World Evidence Lead Scientist (Immunology), UCB Pharma, Raleigh; J.L. Stark, MD, Head of Medical Affairs (Rheumatology), UCB Pharma, Smyrna; R.Y. Suruki, ScD, Real World Evidence Strategy Lead (Immunology), UCB Pharma, Raleigh.
- Address correspondence to Dr. V.S. Sloan, UCB Pharma, 8010 Arco Corporate Dr., Raleigh, North Carolina 27617, USA. E-mail: Victor.Sloan{at}ucb.com